BidaskClub Downgrades AMAG Pharmaceuticals (AMAG) to Sell - Fairfield Current
BidaskClub Downgrades AMAG Pharmaceuticals (AMAG) to Sell Fairfield Current
AMAG Pharmaceuticals (NASDAQ:AMAG) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued to clients ...
Comments
Post a Comment